Literature DB >> 23124503

Head and neck cancer disparity in underserved communities: probable causes and the ethics involved.

Charles E Moore1, Rueben Warren, Sandy D Maclin.   

Abstract

Head and neck cancers are a cause of morbidity and mortality throughout the United States. For low-income, African American men they are one of the leading causes of excess cancer deaths: although all racial/ethnic groups suffer from these cancers, African American men disproportionately suffer and die from them. Low-income communities have increased risks for many adverse health conditions because of environmental factors and existing social determinants of health. These social determinants often lead to unhealthy life circumstances and ineffective coping behaviors. Early detection enhances effective treatment options, but such services are limited among African Americans, particularly African American men in underserved areas. Not addressing oral cancer because of these social conditions reflects unjust and unethical behavior by health care professionals. In Atlanta, one high-density, limited-resource area has the highest incidence of oral cavity cancers. Health Education, Assessment and Leadership (HEAL) was created to address the oral cancer incidence and prevalence, an example of a preventable health disparity between this underserved region and surrounding communities.

Entities:  

Mesh:

Year:  2012        PMID: 23124503     DOI: 10.1353/hpu.2012.0165

Source DB:  PubMed          Journal:  J Health Care Poor Underserved        ISSN: 1049-2089


  9 in total

Review 1.  Racial Disparity Among the Head and Neck Cancer Population.

Authors:  Pedram Daraei; Charles E Moore
Journal:  J Cancer Educ       Date:  2015-09       Impact factor: 2.037

Review 2.  Mitochondrion: I am more than a fuel server.

Authors:  Santanu Dasgupta
Journal:  Ann Transl Med       Date:  2019-10

3.  Dying to be Screened: Exploring the Unequal Burden of Head and Neck Cancer in Health Provider Shortage Areas.

Authors:  Shruthi K Rereddy; Demetrice R Jordan; Charles E Moore
Journal:  J Cancer Educ       Date:  2015-09       Impact factor: 2.037

4.  Travel distance is associated with stage at presentation and laryngectomy rates among patients with laryngeal cancer.

Authors:  Elliot Morse; Shivangi Lohia; Laura M Dooley; Piyush Gupta; Benjamin R Roman
Journal:  J Surg Oncol       Date:  2021-08-14       Impact factor: 2.885

5.  Patient and Provider Perspectives Regarding Enrollment in Head and Neck Cancer Research.

Authors:  Andrew G Shuman; Michele C Gornick; Collin Brummel; Madison Kent; Kayte Spector-Bagdady; Elliot Biddle; Carol R Bradford; J Chad Brenner
Journal:  Otolaryngol Head Neck Surg       Date:  2019-12-10       Impact factor: 5.591

6.  An assessment of racial differences in epidemiological, clinical and psychosocial factors among head and neck cancer patients at the time of surgery.

Authors:  Anvesh Kompelli; Kathleen B Cartmell; Katherine R Sterba; Anthony J Alberg; Christopher C Xiao; Amit J Sood; Elizabeth Garrett-Mayer; Shai J White-Gilbertson; Steven A Rosenzweig; Terry A Day
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2020-03-05

7.  Five-year standardised mortality ratios in a cohort of homeless people in Dublin.

Authors:  Jo-Hanna Ivers; Lina Zgaga; Bernie O'Donoghue-Hynes; Aisling Heary; Brian Gallwey; Joe Barry
Journal:  BMJ Open       Date:  2019-01-25       Impact factor: 2.692

8.  Carbon footprint reduction associated with a surgical outreach clinic.

Authors:  David Forner; Chad Purcell; Victoria Taylor; Christopher W Noel; Larry Pan; Matthew H Rigby; Martin Corsten; Jonathan R Trites; Antoine Eskander; Ted McDonald; S Mark Taylor
Journal:  J Otolaryngol Head Neck Surg       Date:  2021-04-19

9.  Socioeconomic and Other Demographic Disparities Predicting Survival among Head and Neck Cancer Patients.

Authors:  Seung Hee Choi; Jeffrey E Terrell; Karen E Fowler; Scott A McLean; Tamer Ghanem; Gregory T Wolf; Carol R Bradford; Jeremy Taylor; Sonia A Duffy
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.